Positron emission tomography

Frederic H. Fahey, Ramsey D Badawi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

In the 1960s and 1970s, positron emission tomography (PET) was developed as a research tool, particularly for the investigation of neurophysiology.1-4 In the 1980s and 1990s, the clinical utility of PET in oncology, neurology, and cardiology was demonstrated.5-10 The approval of reimbursement by the U.S. Centers for Medicare and Medicaid Services for oncologic PET and the subsequent establishment of regional distribution centers of fluorine-18 (18F)-fluoro-2-deoxy-glucose (FDG) in the late 1990s contributed greatly to the expansion in the clinical use of PET. This expansion led to greater availability of PET for pediatric imaging as well as for adults.11,12 Pediatric PET has demonstrated utility in neurology as well as oncology, and the application of PET in pediatrics will continue to grow as its clinical potential is further realized and as new positron-emitting radiopharmaceuticals are developed. Several technologic factors, involving both physics and radiopharmaceutical chemistry, have contributed to the popularity of PET. It is substantially easier to develop a PET rather than a single photon emission computed tomography (SPECT) analogue to many naturally occurring, biologically relevant chemicals such as water, oxygen, carbon monoxide, ammonia, glucose, and a whole host of others. Thus PET is well suited to serve a very prominent role in this new and exciting era of molecular medicine.

Original languageEnglish (US)
Title of host publicationPediatric Nuclear Medicine/PET: Third Edition
PublisherSpringer New York
Pages484-504
Number of pages21
ISBN (Print)038732321X, 9780387323213
DOIs
StatePublished - 2007

Fingerprint

Positron-Emission Tomography
Radiopharmaceuticals
Pediatrics
Neurology
Molecular Medicine
Glucose
Centers for Medicare and Medicaid Services (U.S.)
Fluorine
Physics
Carbon Monoxide
Single-Photon Emission-Computed Tomography
Cardiology
Ammonia
Electrons
Oxygen
Water
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fahey, F. H., & Badawi, R. D. (2007). Positron emission tomography. In Pediatric Nuclear Medicine/PET: Third Edition (pp. 484-504). Springer New York. https://doi.org/10.1007/978-0-387-32322-0_18

Positron emission tomography. / Fahey, Frederic H.; Badawi, Ramsey D.

Pediatric Nuclear Medicine/PET: Third Edition. Springer New York, 2007. p. 484-504.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fahey, FH & Badawi, RD 2007, Positron emission tomography. in Pediatric Nuclear Medicine/PET: Third Edition. Springer New York, pp. 484-504. https://doi.org/10.1007/978-0-387-32322-0_18
Fahey FH, Badawi RD. Positron emission tomography. In Pediatric Nuclear Medicine/PET: Third Edition. Springer New York. 2007. p. 484-504 https://doi.org/10.1007/978-0-387-32322-0_18
Fahey, Frederic H. ; Badawi, Ramsey D. / Positron emission tomography. Pediatric Nuclear Medicine/PET: Third Edition. Springer New York, 2007. pp. 484-504
@inbook{4c62350938184ab7bab3bb9eb81a3705,
title = "Positron emission tomography",
abstract = "In the 1960s and 1970s, positron emission tomography (PET) was developed as a research tool, particularly for the investigation of neurophysiology.1-4 In the 1980s and 1990s, the clinical utility of PET in oncology, neurology, and cardiology was demonstrated.5-10 The approval of reimbursement by the U.S. Centers for Medicare and Medicaid Services for oncologic PET and the subsequent establishment of regional distribution centers of fluorine-18 (18F)-fluoro-2-deoxy-glucose (FDG) in the late 1990s contributed greatly to the expansion in the clinical use of PET. This expansion led to greater availability of PET for pediatric imaging as well as for adults.11,12 Pediatric PET has demonstrated utility in neurology as well as oncology, and the application of PET in pediatrics will continue to grow as its clinical potential is further realized and as new positron-emitting radiopharmaceuticals are developed. Several technologic factors, involving both physics and radiopharmaceutical chemistry, have contributed to the popularity of PET. It is substantially easier to develop a PET rather than a single photon emission computed tomography (SPECT) analogue to many naturally occurring, biologically relevant chemicals such as water, oxygen, carbon monoxide, ammonia, glucose, and a whole host of others. Thus PET is well suited to serve a very prominent role in this new and exciting era of molecular medicine.",
author = "Fahey, {Frederic H.} and Badawi, {Ramsey D}",
year = "2007",
doi = "10.1007/978-0-387-32322-0_18",
language = "English (US)",
isbn = "038732321X",
pages = "484--504",
booktitle = "Pediatric Nuclear Medicine/PET: Third Edition",
publisher = "Springer New York",

}

TY - CHAP

T1 - Positron emission tomography

AU - Fahey, Frederic H.

AU - Badawi, Ramsey D

PY - 2007

Y1 - 2007

N2 - In the 1960s and 1970s, positron emission tomography (PET) was developed as a research tool, particularly for the investigation of neurophysiology.1-4 In the 1980s and 1990s, the clinical utility of PET in oncology, neurology, and cardiology was demonstrated.5-10 The approval of reimbursement by the U.S. Centers for Medicare and Medicaid Services for oncologic PET and the subsequent establishment of regional distribution centers of fluorine-18 (18F)-fluoro-2-deoxy-glucose (FDG) in the late 1990s contributed greatly to the expansion in the clinical use of PET. This expansion led to greater availability of PET for pediatric imaging as well as for adults.11,12 Pediatric PET has demonstrated utility in neurology as well as oncology, and the application of PET in pediatrics will continue to grow as its clinical potential is further realized and as new positron-emitting radiopharmaceuticals are developed. Several technologic factors, involving both physics and radiopharmaceutical chemistry, have contributed to the popularity of PET. It is substantially easier to develop a PET rather than a single photon emission computed tomography (SPECT) analogue to many naturally occurring, biologically relevant chemicals such as water, oxygen, carbon monoxide, ammonia, glucose, and a whole host of others. Thus PET is well suited to serve a very prominent role in this new and exciting era of molecular medicine.

AB - In the 1960s and 1970s, positron emission tomography (PET) was developed as a research tool, particularly for the investigation of neurophysiology.1-4 In the 1980s and 1990s, the clinical utility of PET in oncology, neurology, and cardiology was demonstrated.5-10 The approval of reimbursement by the U.S. Centers for Medicare and Medicaid Services for oncologic PET and the subsequent establishment of regional distribution centers of fluorine-18 (18F)-fluoro-2-deoxy-glucose (FDG) in the late 1990s contributed greatly to the expansion in the clinical use of PET. This expansion led to greater availability of PET for pediatric imaging as well as for adults.11,12 Pediatric PET has demonstrated utility in neurology as well as oncology, and the application of PET in pediatrics will continue to grow as its clinical potential is further realized and as new positron-emitting radiopharmaceuticals are developed. Several technologic factors, involving both physics and radiopharmaceutical chemistry, have contributed to the popularity of PET. It is substantially easier to develop a PET rather than a single photon emission computed tomography (SPECT) analogue to many naturally occurring, biologically relevant chemicals such as water, oxygen, carbon monoxide, ammonia, glucose, and a whole host of others. Thus PET is well suited to serve a very prominent role in this new and exciting era of molecular medicine.

UR - http://www.scopus.com/inward/record.url?scp=77952248485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952248485&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-32322-0_18

DO - 10.1007/978-0-387-32322-0_18

M3 - Chapter

AN - SCOPUS:77952248485

SN - 038732321X

SN - 9780387323213

SP - 484

EP - 504

BT - Pediatric Nuclear Medicine/PET: Third Edition

PB - Springer New York

ER -